Bimuno GOS
What it is: Galactooligosaccharide (GOS) with 20 human clinicals on gut, immune support and cognitive health, including symptom relief of irritable bowel syndrome (IBS), inflammation biomarkers, increasing activity of natural killer (NK) cells and supporting the gut-brain axis.
Emblematic science: A study found Bimuno GOS was superior to a traditional GOS in increasing bifidobacterial species and at a lower dose. A 2015 double-blind, placebo-controlled study for 10 weeks using 5.5 g/d on 40 elderly subjects age 65-80 found positive influence on gut microbiota, immune parameters and metabonomics, suggesting use in positively affecting the microbiota and markers of immune function associated with aging.
Innovation: Targeted prebiotic with a proprietary composition of GOS has a unique blend of qualities that feeds and stimulates the growth of bifidobacteria.
[To read about the NutriScience ButyraGen, the OptiBiotix ButyraGen and the Orgenetics ButyraGen, download the free NPI digital magazine.]